GE HealthCare's New PET/CT System Receives CE Mark Certification
Chicago, Friday, 28 November 2025.
GE HealthCare’s Omni 128cm PET/CT system, designed for enhanced cancer diagnostics, earns CE Mark, promising improved clinical workflows and patient outcomes with advanced imaging capabilities.
Innovative Imaging Technology
The GE HealthCare Omni 128cm PET/CT system represents a significant leap forward in medical imaging technology, designed to accommodate head-to-thigh imaging in a single bed position. This capability reduces the need for multiple bed positions from typically 5-6 to just 1, thus streamlining the scanning process and improving efficiency [1][2].
Impact on Cancer Diagnostics
This state-of-the-art system is expected to play a crucial role in enhancing cancer diagnosis, staging, and treatment planning. Its ability to provide comprehensive imaging in a single scan allows for earlier detection and more accurate staging of various cancers, which is essential given the projected 77% increase in global cancer rates by 2050 [1][2][3].
Technological Advancements
Leveraging NVIDIA’s full stack accelerated computing platform, the Omni 128cm PET/CT system optimizes the reconstruction process, significantly reducing the time required to generate high-quality images. This not only improves workflow but also decreases the radiation dose and scan time, particularly benefiting sensitive populations like pediatric patients [1][2][3].
Future of Precision Health
GE HealthCare’s ongoing commitment to precision health is underscored by this innovative development. By supporting new clinical pathways and the evaluation of novel PET tracers and emerging theranostic agents, the Omni 128cm system is set to empower clinicians to deliver more personalized and efficient care, thus shaping the future of healthcare delivery across Europe [1][3].